114 related articles for article (PubMed ID: 15353351)
1. HTLV envelopes and their receptor GLUT1, the ubiquitous glucose transporter: a new vision on HTLV infection?
Manel N; Taylor N; Kinet S; Kim FJ; Swainson L; Lavanya M; Battini JL; Sitbon M
Front Biosci; 2004 Sep; 9():3218-41. PubMed ID: 15353351
[TBL] [Abstract][Full Text] [Related]
2. Separate cellular localizations of human T-lymphotropic virus 1 (HTLV-1) Env and glucose transporter type 1 (GLUT1) are required for HTLV-1 Env-mediated fusion and infection.
Maeda Y; Terasawa H; Tanaka Y; Mitsuura C; Nakashima K; Yusa K; Harada S
J Virol; 2015 Jan; 89(1):502-11. PubMed ID: 25339765
[TBL] [Abstract][Full Text] [Related]
3. Neuropilin-1 is involved in human T-cell lymphotropic virus type 1 entry.
Ghez D; Lepelletier Y; Lambert S; Fourneau JM; Blot V; Janvier S; Arnulf B; van Endert PM; Heveker N; Pique C; Hermine O
J Virol; 2006 Jul; 80(14):6844-54. PubMed ID: 16809290
[TBL] [Abstract][Full Text] [Related]
4. Tropical spastic paraparesis and HTLV-1 associated myelopathy: clinical, epidemiological, virological and therapeutic aspects.
Gessain A; Mahieux R
Rev Neurol (Paris); 2012 Mar; 168(3):257-69. PubMed ID: 22405461
[TBL] [Abstract][Full Text] [Related]
5. Human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2 use different receptor complexes to enter T cells.
Jones KS; Fugo K; Petrow-Sadowski C; Huang Y; Bertolette DC; Lisinski I; Cushman SW; Jacobson S; Ruscetti FW
J Virol; 2006 Sep; 80(17):8291-302. PubMed ID: 16912281
[TBL] [Abstract][Full Text] [Related]
6. Adult T cell leukemia following HTLV-I-associated myelopathy/tropical spastic paraparesis: case reports and implication to the natural course of ATL.
Tamiya S; Matsuoka M; Takemoto S; Shimizu K; Yamaguchi K; Mita S; Uchino M; Ando M; Miyaguni T; Kuniyoshi K
Leukemia; 1995 Oct; 9(10):1768-70. PubMed ID: 7564523
[TBL] [Abstract][Full Text] [Related]
7. The ubiquitous glucose transporter GLUT-1 is a receptor for HTLV.
Manel N; Kim FJ; Kinet S; Taylor N; Sitbon M; Battini JL
Cell; 2003 Nov; 115(4):449-59. PubMed ID: 14622599
[TBL] [Abstract][Full Text] [Related]
8. Immunopathogenesis of HTLV-1-assoaciated myelopathy/tropical spastic paraparesis (HAM/TSP).
Fuzii HT; da Silva Dias GA; de Barros RJ; Falcão LF; Quaresma JA
Life Sci; 2014 May; 104(1-2):9-14. PubMed ID: 24704970
[TBL] [Abstract][Full Text] [Related]
9. HTLV-I serostatus of mothers of patients with adult T-cell leukemia and HTLV-I-associated myelopathy/tropical spastic paraparesis.
Bartholomew C; Jack N; Edwards J; Charles W; Corbin D; Cleghorn FR; Blattner WA
J Hum Virol; 1998; 1(4):302-5. PubMed ID: 10195256
[TBL] [Abstract][Full Text] [Related]
10. Human T cell leukemia virus envelope binding and virus entry are mediated by distinct domains of the glucose transporter GLUT1.
Manel N; Battini JL; Sitbon M
J Biol Chem; 2005 Aug; 280(32):29025-9. PubMed ID: 15955807
[TBL] [Abstract][Full Text] [Related]
11. Target epitopes of HTLV-1 recognized by class I MHC-restricted cytotoxic T lymphocytes in patients with myelopathy and spastic paraparesis and infected patients with autoimmune disorders.
Kozako T; Akimoto M; Toji S; White Y; Suzuki S; Arima T; Suruga Y; Matsushita K; Shimeno H; Soeda S; Kubota R; Izumo S; Uozumi K; Arima N
J Med Virol; 2011 Mar; 83(3):501-9. PubMed ID: 21264872
[TBL] [Abstract][Full Text] [Related]
12. GLUT1 is not the primary binding receptor but is associated with cell-to-cell transmission of human T-cell leukemia virus type 1.
Takenouchi N; Jones KS; Lisinski I; Fugo K; Yao K; Cushman SW; Ruscetti FW; Jacobson S
J Virol; 2007 Feb; 81(3):1506-10. PubMed ID: 17108050
[TBL] [Abstract][Full Text] [Related]
13. HTLV-1 and -2 envelope SU subdomains and critical determinants in receptor binding.
Kim FJ; Manel N; Garrido EN; Valle C; Sitbon M; Battini JL
Retrovirology; 2004 Dec; 1():41. PubMed ID: 15575958
[TBL] [Abstract][Full Text] [Related]
14. Polymorphisms at GLUT1 gene are not associated with the development of TSP/HAM in Brazilian HTLV-1 infected individuals and the discovery of a new polymorphism at GLUT1 gene.
Costa GC; Azevedo R; Gadelha SR; Kashima SH; Muricy G; Olavarria VN; Covas DT; Takayanagui OM; Galvão-Castro B; Alcantara LC
J Med Virol; 2009 Mar; 81(3):552-7. PubMed ID: 19152396
[TBL] [Abstract][Full Text] [Related]
15. Human T cell lymphotropic virus type I (HTLV-I)-specific CD4+ T cells: immunodominance hierarchy and preferential infection with HTLV-I.
Goon PK; Igakura T; Hanon E; Mosley AJ; Barfield A; Barnard AL; Kaftantzi L; Tanaka Y; Taylor GP; Weber JN; Bangham CR
J Immunol; 2004 Feb; 172(3):1735-43. PubMed ID: 14734756
[TBL] [Abstract][Full Text] [Related]
16. Molecular aspects of HTLV-1 entry: functional domains of the HTLV-1 surface subunit (SU) and their relationships to the entry receptors.
Jones KS; Lambert S; Bouttier M; Bénit L; Ruscetti FW; Hermine O; Pique C
Viruses; 2011 Jun; 3(6):794-810. PubMed ID: 21994754
[TBL] [Abstract][Full Text] [Related]
17. The receptor complex associated with human T-cell lymphotropic virus type 3 (HTLV-3) Env-mediated binding and entry is distinct from, but overlaps with, the receptor complexes of HTLV-1 and HTLV-2.
Jones KS; Huang YK; Chevalier SA; Afonso PV; Petrow-Sadowski C; Bertolette DC; Gessain A; Ruscetti FW; Mahieux R
J Virol; 2009 May; 83(10):5244-55. PubMed ID: 19279090
[TBL] [Abstract][Full Text] [Related]
18. Rapid syncytium formation between human T-cell leukaemia virus type-I (HTLV-I)-infected T-cells and human nervous system cells: a possible implication for tropical spastic paraparesis/HTLV-I associated myelopathy.
Mor-Vaknin N; Turgeman H; Torgeman A; Wolfson M; Huleihel M; Aboud M
Cell Biol Int; 1998; 22(2):95-103. PubMed ID: 9878096
[TBL] [Abstract][Full Text] [Related]
19. Control of Human T-Cell Leukemia Virus Type 1 (HTLV-1) Infection by Eliminating Envelope Protein-Positive Cells with Recombinant Vesicular Stomatitis Viruses Encoding HTLV-1 Primary Receptor.
Tezuka K; Okuma K; Kuramitsu M; Matsuoka S; Tanaka R; Tanaka Y; Hamaguchi I
J Virol; 2018 Feb; 92(4):. PubMed ID: 29212930
[TBL] [Abstract][Full Text] [Related]
20. Human T cell leukemia virus type I-induced disease: pathways to cancer and neurodegeneration.
Barmak K; Harhaj E; Grant C; Alefantis T; Wigdahl B
Virology; 2003 Mar; 308(1):1-12. PubMed ID: 12706085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]